Two Sigma Securities’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,085
Closed -$20.5K 1334
2025
Q2
$20.5K Buy
+10,085
New +$17.5K ﹤0.01% 1205
2021
Q4
Sell
-11,276
Closed -$76K 1512
2021
Q3
$76K Buy
+11,276
New +$80.7K ﹤0.01% 1344

Other funds holding ACIU

Two Sigma Securities's ACIU Position: Q3 2025 in Review

Two Sigma Securities sold out of AC Immune (ACIU) in Q3 2025, closing a stake of 10,085 shares — an estimated $20.5K sold.

Two Sigma Securities first reported a position in ACIU in Q3 2021 and held it in 2 quarters. The position peaked at $76K in Q3 2021. 40 funds tracked by Wall St. Rank hold ACIU as of Q3 2025.

  • Two Sigma Securities reported no remaining AC Immune position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 10,085 AC Immune shares in Q3 2025, an estimated $20.5K.
  • Two Sigma Securities first reported a position in AC Immune in Q3 2021 and held it in 2 quarters.
  • Two Sigma Securities's AC Immune position peaked at $76K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held AC Immune as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.